CHALLENGES IN FORMULATING HERBAL COSMETICS
The herbal cosmetics are prepared by phytochemicals that occur in a variety of botanical sources, that influences the physiology of skin and provide nutrients that are necessary for the healthy skin or hair. These products are utilized for daily purposes, which include herbal shampoo, herbal conditioner, herbal face wash, herbal soap, etc. These products are classified as a different category by regulatory agencies. However, guidelines of these certifying agencies have no harmonization, and many cosmetic industries prepare and package these formulations in an irrationalway. Many cosmetic products have natural products in their formulation that perform a specific biological function, but these products should be evaluated on their toxicological and efficacy aspects. The contribution of developing countries is very poor in global herbal business because of lack of standardization measures and quality control. The lack of safety and efficacy data on herbal cosmetics renders it difficult to meet the criteria needed for supporting its use worldwide. This review article discusses challenges related to regulatory status, quality control, standardization, certification, drug processing and the opportunities for herbal cosmetics in local as well as the global scenario. The search criteria used in the present review were the keywords mentioned in the manuscript and articles from major scientific resources were cited. The articles from 1952 to 2018 were specifically referred, but few references from 19 century were also cited to support the prevalence of scientific principles in the development of herbal cosmetics in the ancient era.
2. Sahu AN, Jha S, Dubey SD. Formulation and evaluation of curcuminoid based herbal face cream. Indo Global J Pharm Sci 2011;1:77-84.
3. Pandey S, Meshya N, Viral D. Herbs play an important role in the field of cosmetics. Int J Pharm Tech Res 2010;2:632-9.
4. Gediya SK, Mistry RB, Patel UK, Blessy M, Jain HN. Herbal plants: used as cosmetics. J Nat Prod Plant Resour 2011;1:24-32.
5. Saha R. Cosmeceuticals and herbal drugs: practical uses. Int J Pharm Res Allied Sci 2012;3:59-65.
6. Sharma HD, Paramesh R. Trends in ageing and skin care: Ayurvedic concepts. J Ayurveda Integr Med 2010;1:110â€“3.
7. Top 7 Advantages of using Natural Cosmetics. Available from: www.thenewecologist.com. [Last accessed on 12 Nov 2018]
8. Akinyele BO, Odiyi AC. Comparative study of the vegetative morphology and the existing taxonomic status of Aloevera. J Plant Sci 2007;2:558-63.
9. Escamilla M, Ferre A, Hidalgo C, Fuentes N, Kaps R. Revision of European ecolabel criteria for soaps, shampoos and hair conditioners. Joint Res Centre Eur Commission Int J Pharm Sci 2012;8:1-40.
10. Suzuki D. The Dirty Dozenâ€ Ingredients Investigated in the David Suzuki Foundation Survey of Chemicals in Cosmetics; 2010;1-15. Available from: https://davidsuzuki.org/wp-content/uploads/2017/10/dirty-dozen-cosmetics-ingredients-backgrounder.pdf. [Last accessed on 01 Dec 2017]
11. Database. On occupational exposure to hazardous agents. Available from: https://coldwarpatriots.org/database-of-occupational-exposure-to-hazardous-agents-hazmap/. [Last accessed on 02 Dec 2017].
12. International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans 1978;84:1-365.
13. Kadam VS, Chintale AG, Deshmukh KP, Nalwad DN. Cosmeceuticals an emerging concept: a comprehensive review. Int J Res Pharm Chem 2013;3:308-16.
14. Winter RA. Consumers dictionary of cosmetic ingredients. Three Rivers press United states USA. 7th ed.; 2009. Available from: https://www.amazon.com/Consumers-Dictionary-Food-Additives-7th/dp/0307408922. [Last accessed on 21 Nov 2017]
15. Upadhyaya SC. Ratirahasya (13th Cen A. D.) Mumbai: D. R. Taraporevala Sons and Co. Pri. Ltd; 1965. p. 96.
16. Bhishagaratna KL. An english translation of sushruta-samhita (176-340 A. D)â€“the chokhamba sanskrit series office, Varanasi: Chapter 20:37.5.; 1963. p. 455.
17. Bhishagaratna KL. Atridev-vagbhat.-ashtang hridaya-shri vagbhatvirachita (Later half of 5thCen A. D.) Varanasi: Chaukhamba Sanskrit Series Office; 1962.
18. Sharma T. Nagarasarvaswam-padmashrivirachit (10thCen. A. D.) manilal desai, Fort, MumLad GP. Archeology and Mahabharata. Pune: Deccan College Postgraduate Research Institute; 1978.
19. Patkar KB, Bole PV. Herbal cosmetics in ancient India with a treatise on planta cosmetic. Bharatiya Vidya Bhavan Mumbai, India Mumbai: World Wide Fund for Nature; 1997.
20. Rao SA. Sri Sarabhendra Vaidya Ratnavali. In: Krishnaswami Mahadick. editor. Saraswati Mahal Library: Tanjore; 1952. p. 277, 351, 4, 9, 81.
21. Mukerji B. The Indian pharmaceutical codex-council of scientific and industrial research. Council of Scientific and Indrustrial Research. Vol. 1. New Delhi; 1953. p. 223-8.
22. Rao SA. Sri sarabhendra vaidya ratnavali. In: Krishnaswami Mahadick. editor. Saraswati Mahal Library: Tanjore; 1952. p. 277, 351, 354, 359, 381.
23. Watson JF. Index to the native and scientific, names of economic plants. In: Eyre GE, Spottiswoods W. editors. London; 1866. p. 412.
24. Anon. Maharashtra State Gazetteer. Vol. A. Mumbai: Bot Gen Miscellaneous Plants-Govt Printing Press; 1961. p. 84. Part III.
25. Mishra J. Shri Kamaratnam-Nityanathvirachitam (13th Cent. A. D.) Kalyan, Lakshmi Venkatesswar Prakashan: Mumbai; 1897. p. 93.
26. Lal BB. The Saraswati flows on: The Continuity of Indian Culture; 2002.
27. Mahabharata. Bhandarkar oriental research institute. Viratparva. Chap.3:17, 8:16, Aadiparva. Chap. 213:44.
28. Lad GP. Archeology and Mahabharata. Pune: Deccan college postgraduate research institute; 1978.
29. Notes of Guidance for Testing of Cosmetic Ingredients for Their Safety Evaluation. 4th rev; 2000. Available from: https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_006.pdf. [Last accessed on 04 Dec 2017].
30. Oakland JS. Management tools in the manufacture of chemicals: statistical quality control. Chem Ind 1981;16:562-7.
31. Pierre M. Sampling of particulate materials theory and practice. 2nded. New York; 1979.
32. Sommer K. Sampling of powders and bulk materials. Heidelberg, Springer-Verlag; 1986. Available from: https://books.google.co.in/ books?hl=enandlr=andid=SDD6CAAAQBAJandoi=fndandpg=PA1anddq=32.+Sommer+K.+Sampling+of+powders+and+bulk+materials.+Heidelberg,+Springer-Verlag,+1986andots=z964KFqSY_andsig=8l6KsydN1-RC2KFNOVzx5X-yeJw#v=onepageandqandf=false. [Last accessed on 07 Jan 2017]
33. Sampling procedures for inspection by attributes. Procedures for assessment of stated quality levels. British Standard BS 6001-5:2000. Geneva, International Organization for Standardization; 1999. Available from: http://www.who.int/ medicines/areas/ quality_safety/quality_assurance/GuidelinesSamplingPharmProductsTRS929Annex4.pdf [Last accessed on 21 Jan 2018]
34. Sampling procedures for inspection by variables. Specification for single sampling plans indexed by acceptable quality level (AQL) for lot-by-lot inspection. British Standard BS 6002-1. Geneva, International Organization for Standardization; 1989. Available from: https://www.iso.org/standard/9602.htm. [Last accessed on 21 Nov 2018]
35. Sampling procedures for inspection by attributes. Sampling schemes indexed by acceptance quality limit for lot-by-lot inspection. British Standard BS 6001-1. Geneva, International Organization for Standardization; 1999. p. 2859-1. Available from: https://www.iso.org/obp/ui/#iso: std: iso: 2859:-1:ed-2:en. [Last accessed on 20 Dec 2017]
36. American National Standards Institute/American Society for Quality. Sampling procedures and tables for inspection by attributes. Washington, DC, American Society for Quality; 1993 Available from: http://vcg1.com/files/ANSI_ASQC-Z1.4. pdf. [Last accessed on 02 Nov 2017]
37. Methods for sampling chemical products. Introduction and general principles. British Standard BS 5309-1. London, British Standards Publishing; 1976. Available from: www.who.int/medicines/areas/quality_safety/./QualityAssurancePharmVol2.pdf. [Last accessed on 26 Jan 2018]
38. Methods for sampling chemical products. Sampling of liquids. British Standard BS 5309-3. London, British Standards Publishing; 1976. Available from: www.who.int/medicines/ areas/quality_safety/./QualityAssurancePharmVol2.pdf. [Last accessed on 22 Jan 2018]
39. US Food and Drug Administration. Guidance for Industry: Botanical drug products; 2004. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070491.pdf. [Last accessed on 23 Jan 2018]
40. Geneva, Switzerland: World Health Organization Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products. (Document reference (who/TDR/GEN/Guidance/051); 2005. Available from: www.who.int/tdr/publications/tdr-research-publications/operational-guidance/en/. [Last accessed on 21 Dec 2017]
41. Acceptance sampling plans and procedures for the inspection of bulk materials. Geneva, International Organization for Standardization; 2000. Available from: https://www.iso.org/ standard/33418.html. [Last accessed on 14 Nov 2017]
42. Ernst E, Siev-Ner I, Games D. Complementary medicine-a critical review. Isr J Med Sci 1997;33:808-15.
43. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978;88:251-8.
44. Bundesverb and Deutscher Industrie und Handelsunternehmen (BDIH) in Germany; Available from https://www.bdih.de/. [Last accessed on 12 Jan 2018]
45. Soil Association Organic Standard in United Kingdom. Available from: https://www.soilassociation.org/certification/. [Last accessed on 14 Jan 2018]
46. Cosmetics Organic Standard (Cosmos) in European Union (EU). Available from: https://cosmos-standard.org/. [Last accessed on 02 Dec 2017].
47. ECOCERT in France. Available from: www.ecocert.in. [Last accessed on 10 Nov 2017]
48. National Association for Sustainable Agriculture, Australia (NASAA) in Australia. Available from: https://www. nasaa.com.au. [Last accessed on 16 Dec 2017]
49. Istituto per la Certificazione Etica e Ambientale (ICEA) in Italy. Available from: http://icea.bio/. [Last accessed on 27 Dec 2017]
50. InstitutoBiodinÃ¢mico de CertificaÃ§Ãµes (IBD) in Brazil. Available from: http://ibd.com.br/pt/IbdOrganico.aspx. [Last accessed on 13 Nov 2017]
51. Oregon Tilth in the United States of America; Available from https://tilth.org/. [Last accessed on 10 Nov 2017]
52. Kambooj A. Anaytical Evaluation of Herbal Drugs. Available from: http://cdn.intechopen.com/pdfs/32437/InTech-Analytical_ evaluation_of_herbal_drugs.pdf. [Last accessed on 21 Jan 2018]
53. Skoog DA, West DM, Holler FJ. Fundamentals of analytical chemistry. 8th ed. Fort Worth: Saunders College Pub; 1996. Available from: https://www.pdfdrive.com/title-fundamentals -of-analytical-chemistry-8th-edition-student-e4247391.html. [Last accessed on 06 Dec 2017].
54. Swartz ME, Krull IS. Analytical method development and validation. Marcel Dekker, Inc; New York: 1997. Available from: https://pubs.acs.org/doi/abs/10.1021/ja975573z. [Last accessed on 10 Nov 2017]
55. Food and Drug Administration. Current Good Manufacturing Practice for Finished Pharmaceuticals. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211. [Last accessed on 08 Dec 2017]
56. Food and Drug Administration. Current Good Manufacturing Practice in Manufacturing, Packaging, Labelling, or Holding Operations for Dietary Supplements. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=111. [Last accessed on 08 Dec 2017]
57. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Methods: Definitions and Terminology; Geneva, Switzerland: ICH Secretariat; 2010. Available from: http://www.ich.org/cache/compo/276-254-1.html. [Last accessed on 14 Dec 2017]
58. Center for Drug Evaluation and Research, Center for Biologicals Evaluation and Research, Food and Drug Administration. Guidance for Industry-Analytical Procedures and Methods Validation-Chemistry, Manufacturing, and Controls Documentation Draft Guidance. Department of Health and Human Services; Rockville, MD; 2000. Available from: http://www.msk.nclinnovations.org/medregulations/v1/html/Guidance/Guidance_Analytical%20Method%20and%20Validation.pdf [Last accessed on 02 Jan 2018]
59. AOAC International. Single Laboratory Validation Acceptance Criteria (Chemical Methods) AOAC International; Gaithersburg, MD; 2002. Available from: http://www.aoac.org/ dietsupp6/ Dietary-Supplement-web-site/SLV_criteria.pdf. [Last accessed on 04 Dec 2017]
60. AOAC International. Single Laboratory Validation-Generic Protocol. AOAC International; Gaithersburg, MD; 2002. Available from: http://www.aoac.org/dietsupp6/Dietary-Supplement-web-site/SLVGeneric.pdf. [Last accessed on 07 Nov 2017]
61. AOAC International. Method Validation. AOAC International; Gaithersbrg, MD; 2010. Available from: http://www.aoac.org/ vmeth/omamanual/omamanual.htm. [Last accessed on 02 Jan 2018]
62. Chadwick L, Fong H. Herb quality assurance and standardization in herb-drug interaction evaluation and documentation. Lam YW, Huang SM, Hall SD, editors. New York: Taylor and Francis. Herb quality assurance and standardization in herb-drug interaction evaluation and documentation; 2006. p. 191â€“203.
63. Geneva: World Health Organization; World Health Organization. Regulatory Situation of Herbal Medicines. A Worldwide Review; 1998. Available from: http://apps.who.int/iris/handle/ 10665/63801 [Last accessed on 03 Nov 2017]
64. Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 2002;1:287-93.
65. Geneva: World Health Organization. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. 2003 Available from http://apps.who.int/iris/ bitstream/handle/10665/42783/9241546271.pdf.jsessionid=09F846F1069DF6BEC23747D3C280EF8E?sequence=1. [Last accessed on 15 Jan 2017]
66. Geneva: World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. WHO/EDM/TRM; 2000. Available from: http:// apps.who.int/iris/handle/10665/66783. [Last accessed on 20 Dec 2017]
67. Geneva: World Health Organization. Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review. WHO/EDM/TRM; 2001. Available from: http://apps.who.int/medicinedocs/en/d/Jh2943e/. [Last accessed on 21 Nov 2017]
68. Nadkarni KM. Indian plants and drugs with their medicinal properties and uses. Norton and Co. Madras; 1910. p. 120.
69. World Health Organization. Guidelines for the regulation of herbal medicines in the South-East Asia Region. New Delhi, Regional Office for South-East Asia; 2003. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js22299en/. [Last accessed on 05 Nov 2017].
70. Skalli S, Soulaymani Bencheikh R. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 2012;35:785-91.
71. Shetti S, Kumar CD, Sriwastava NK, Sharma IP. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:1-10.
72. Cairo: World Health Organization (WHO), Regional Office for the Eastern Mediterranean; World Health Organization. Guidelines on minimum requirements for the registration of herbal medicinal products in the Eastern Mediterranean Region; 2006. Available from: https://www.paho.org/ blz/index.php?option=com_docmanandview=downloadandalias=223-2006-working-together-for-healthandcategory_slug= technical-documentationandItemid=250. [Last accessed on 08 Nov 2017]
73. Development of Traditional Medicine in the South-East Asia Region. Report of a Regional Consultative Meeting Pyongyang, DPR Korea. World Health Organization, Regional Office for South-East Asia New Delhi; 2005. Available from: http://apps.searo.who.int/PDS_DOCS/B0020.pdf. [Last accessed on 10 Jan 2018]
74. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998;280:1585-9.
75. Barens J, Anderson, Phillipson JD, Newall CA. Herbal Medicines. Vol. 459: London. Pharmaceutical Press; 2007. p. 1-23.
76. Quality criteria and standardization of phytopharmaceuticals: Can acceptable drug standards be achieved? Drug Inform J 1994;32:101â€“10.
77. Bodeker C, Bodeker G, Ong CK, Grundy CK, Burford G, Shein K. WHO global atlas of traditional, complementary and alternative medicine. World Health Organization, Geneva. De Smet PAGM; 2004. Available from: http://apps.who.int/iris/bitstream/ handle/10665/43108/9241562862_map.pdf?sequence=1. [Last accessed on 23 Dec 2017]
78. Keller K, Hansel R, Chandler RF, Smet D. Health risks of herbal remedies. Drug Saf 1992;13:81-93.
79. Duke JA, Martinez RV. Overview of herbal quality control. Drug Inform J 1994;33:717-24.
80. European Agency for the Evaluation of Medicinal Products (EMEA), London. EMEA. Points to Consider on Good Agricultural and Collection Practice for Starting Materials of Herbal Origin; 2002. Available from: http://www.ema. europa.eu/docs/en_GB/document_library/Other/2009/12/WC500018057.pdf. [Last accessed on 07 Oct 2017]
81. Kunle, Folashade O, Egharevba, Omoregie H, Ahmadu, Ochogu P. standardization of herbal medicines-a review. Int J Biodiver Conserve 2012;4:101-12.
82. WHO. Basic Tests for Drugs, Pharmaceutical Substances, Medicinal Plant Materials, and Dosage Forms. World Health Organization, Geneva; 1998. Available from: https://books. google.co.in/books?isbn=9241545372. [Last accessed on 26 Jan 2018]
83. WHO, General Guidelines for Methodologies on Research and Evaluation Traditional Medicine. World Health Organization, Geneva; 2002. Available from: http://apps.who.int/ medicinedocs/ en/d/Jwhozip42e/. [Last accessed on 02 Jan 2018]
84. EMEA guidelines on Quality of Herbal Medicinal Products/ Traditional Medicinal Products, Review. European Agency for the Evaluation of Medicinal Products (EMEA), London; 2005. Available from: http://www.ema.europa.eu/ docs/en_GB/document_ library/Scientific_guideline/2011/09/WC500113209.pdf. [Last accessed on 21 Nov 2017]
85. WHO, Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva; 1992. Available from: http://apps.who.int/iris/handle/10665/41986. [Last accessed on 20 Dec 2017]
86. Adenan MI. Malaysian herbs and herbal products. In A Two and Half Day Course of Herbal and Phytochemical Processing, CEPP short course notes. Chemical Engineering Pilot Plant, UTM, Skudai; 2003. Available from: http://eprints.utm.my/id/eprint/ 54831/ 1/NorAmaizaMohdAminPFChE2015.pdf. [Last accessed on 22 Nov 2017]
87. Arif MT. Traditional/Complementary Medicine: The way ahead. Med J Malasyia 2002;57:261-4.
88. Puteh M. In a Two and Half Day course of Herbal and Phytochemical Processing, CEPP short course notes. Chemical Engineering Pilot Plant, UTM SkudaiJanuary; 2003. Available from: http://www.kolmetz.com/pdf/Foo/IJKM_Phytochemical.pdf. [Last accessed on 17 Jan 2017]
89. Wazir SK. promoting the herbal industry in Malaysia: The Malaysia Herbal Corporation Initiative. In A Two and Half Day course of Herbal and Phytochemical Processing, CEPP short course notes. Chemical Engineering Pilot Plant; 2003. Available from: http://www.ibd.utm.my/files/PDF/tc_HERBALPHYTO04(L)-new.pdf. [Last accessed on 12 Jan 2018]
90. Verma S, Singh SP. Current and future status of herbal medicines. Veterinary World 2008;1:347-50.
91. Padmawar A, Bhadoria U. Phytochemical investigation and comparative evaluation of in vitro free radical scavenging activity of Triphala and Curcumin. AJMPS 2011;1:9-12.
92. Ampofo J, Andoh A, Tetteh W, Bello M. Microbiological profile of some ghanaian herbal preparations-safety issues and implications for the health professions. Open J Med Microbiol 2012;2:121-30.
93. Mosihuzzaman M, Choudhary MI. Protocols on safety, efficacy, standardization, and documentation of herbal medicine. Pure Appl Chem 2008;80:2195-230.
94. Mukama E. The African herbal industry: constraints and challenges. Available from: http://www.academia.edu/3443773/ The_ African_herbal_industry_constraints_and_challenges. [Last accessed on 08 Jan 2018]
95. Kamboj A. Analytical evaluation of herbal drugs. Drug Discovery; 2012. Available from: https://www.intechopen.com/books/drug-discovery-research-in-pharmacognosy/analytical-evaluation-of-herbal-drugs. [Last accessed on 03 Jan 2017]
96. Patkar K. Herbal cosmetics in ancient India. Indian J Plast Surg 2000;41:134â€“7.
97. Galor SW, Benzie IFF. Editors. Herbal medicine: biomolecular and clinical aspects. an introduction to its history, usage, regulation, current trends, and research needs. 2nd ed. Boca Raton: CRC Press; 2011.
98. Erah P. Herbal medicines: challenges, a tropical journal of pharmaceutical research armstrong NC. Br J Clin Pharmacol 2002;1:53-4.
99. Bauer R, Tittel G. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine 1996;2:193-8.
100. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine 2002;9 Suppl 3:1-33.
101. Brevoort P. The U. S. botanical market: an overview. Herbal Gram 2002;251:1005-19.
102. Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 2000;33:179-89.
103. Chaudhary Roy, Chandrashekharan M, Mishra S. Embryotoxicity and teratogenicity studies of ayurvedic contraceptives. J Ethnopharmacol 2001;56:300-1.
104. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003;52:1361-71.
105. Dahanukar SA, Thatte UM. Current status of Ayurveda in phytomedicine. Phytomedicine 1997;4:359-68.
106. Eisenburg MD, David M. Coincidence in pharmaceutical discovery. The impact of biotechnology. Arzneimittel Forschung 1995;45:934-9.
107. Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative
medicine use in the United States, Results of a follow-up national survey. J Am Med Assoc 1998;280:1569-75.
108. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. New Engl J Med 1993;328:246-52.
109. Ernst E, Rand JI, Stevinson C. Complementary therapies for a depression-an overview. Arch Gen Psychiat 1998;55:1026-32.
110. Fisher P, Ward A. Complementary medicine in Europe. Br Med J
111. Grunwald J, Buettel, K. The European phytomedicines market: figures, trends, analysis. Herbal Gram 1995;34:60-5.
112. Marcus D, Grollman A. Botanical medicines-the need for new regulations. New Engl J Med 2002:347.
113. Sivapriya V, Ponnarmadha S, Abdul Azeezand N, Sudarshanadeepa V. Novel nanocarriers for ethnopharmacological formulations. Int J Appl Pharm 2018;1:26-30.
114. Alaayedi M, Mahmood H, Saeed A. The enhancement effect of castor oil on the permeability of flurbiprofen as a transdermal gel. Int J Appl Pharm 2018;10:140-4.